03rd week of 2010 patent applcation highlights part 38 |
Patent application number | Title | Published |
20100015183 | TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE - The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a subject a transmucosal drug delivery device comprising the medicament. Also provided are devices suitable for transmucosal administration of a medicament to a subject and methods of their administration and use. The devices include a medicament disposed in a mucoadhesive polymeric diffusion environment and a barrier environment. | 2010-01-21 |
20100015184 | Methods of Making Pharmaceutical Components for Customized Drug Products - Methods and systems for developing and manufacturing componentized drug product precursor modules that can be simply assembled to create customized drug products are disclosed. Each module contains components of a final drug product (e.g., active pharmaceutical ingredients, nutritional ingredients, and/or excipients) in a fixed mixture selected to maximize desired pharmaceutical characteristics (e.g., stability, manufacturing efficiency) and minimize cost. The modules can be extensively tested for quality and assembled immediately, or at a later time, in multiple combinations to customize the final drug product characteristics (e.g., multiple active ingredients, doses, flavor, viscosity, etc.) to meet individual patient/consumer needs and/or preferences while assuring high quality. Permitted combinations may be maintained in a database to enable networked drug product selection, prescribing, and ordering. Each resulting customized drug product dose can be labeled to facilitate compliance and reduce the number of drug products administered per day. | 2010-01-21 |
20100015185 | BIODEGRADABLE MATERIAL BASED ON OPENED STARCH - The present application relates to a biodegradable material comprising opened starch or a mixture of opened starch and destructurised starch. The biodegradable material comprises about 50 to about 100 wt. % of opened starch or of a mixture of opened starch and destructurised starch, based on the total weight of the biodegradable material, said biodegradable material having a bulk density of 1.0 to 1.5 kg/dm. The biodegradable material is used for manufacturing biodegradable shaped articles, wherein said biodegradable shaped articles are suitable for delivery of a biologically or pharmaceutically active component in or to a vertebrate, e.g. a mammal. | 2010-01-21 |
20100015186 | HYDROGEL PARTICLE - A hydrogel particle contains a continuous phase portion of non-crosslinked hydrogel and a large number of disperse phase portions dispersed in the continuous phase portion. Each of the large number of disperse phase portions is a solid phase containing an oil component and particles of zinc oxide dispersed therein. | 2010-01-21 |
20100015187 | MACRO-SIZED LIPID CAPSULE EMULSION COMPOSITION AND COSMETIC COMPOSITION CONTAINING THE SAME - An emulsion composition of the invention has macro-sized (0.01 to 5 mm) lipid capsule particles and it is for a skin cosmetic composition. An emulsion composition of the invention exhibits improved stability for its particle size by adjusting a size of the particle through a combination of liquid phase oil and integument lipid or lipoid material and encapsulating the liquid phase oil with the integument lipid. The emulsion composition of the invention has unique outward appearance and use feeling due to the macro-sized particles in it, also exhibits excellent skin safety and moisture persistence by containing no surfactant and maintains an activity of an oleophilic effective ingredient which is apt to be oxidized for a long time. | 2010-01-21 |
20100015188 | CORE-SHELL-TYPE CERIUM OXIDE MICROPARTICLE, DISPERSION SOLUTION COMPRISING THE MICROPARTICLE, AND PROCESS FOR PRODUCTION OF THE MICROPARTICLE OR DISPERSION SOLUTION - An object of the present invention is to provide a core-shell-type cerium oxide microparticle, a dispersion solution comprising the microparticle, and a process for production of the microparticle or dispersion solution, and to achieve the object, the present invention provides a core-shell-type cerium oxide microparticle which has an average particle diameter of 30 to 200 nm and a coefficient of variation therein no greater than 0.25, and in which the secondary particle forming the core portion is spherical in shape and a polymer is attached to its surface, a dispersion solution of this cerium oxide microparticle and a dry powder from the cerium oxide microparticle dispersion solution, and a process of producing a core-shell-type cerium oxide microparticle or a dispersion solution thereof, which comprises the steps of: mixing a cerium salt and a polymer in an organic solvent to obtain a mixture; and heating this mixture under reflux at a prescribed temperature to precipitate core-shell-type cerium oxide microparticles, wherein the cerium salt is cerium nitrate and the particle diameter of the microparticles is adjusted using the molecular weight of the polymer. | 2010-01-21 |
20100015189 | COSMETIC COMPOSITION COMPRISING CALCIUM CARBONATE PARTICLES AND A COMBINATION OF SURFACTANTS - The invention concerns a cosmetic composition, in particular for hair care, comprising, in a cosmetically acceptable medium: (a) solid particles containing at least 10 wt. % of carbonate calcium; (b) a combination of at least two surfactants, selected among combinations: of at least an anionic surfactant (i) and of at least an amphoteric surfactant (ii) or of at least an anionic surfactant (i) and of at least a non-ionic surfactant (iii); (c) a cationic polymer whereof the cationic charge density is not more than 7 meq/g and, preferably, not less than 0.05 meq/g. | 2010-01-21 |
20100015190 | Preparation for reducing and/or preventing body fat and respective uses, in particular together with a dressing material - The present invention relates to human metabolism, in particular fat reduction and a cosmetic and pharmaceutical formulation, as well as respective uses in particular together with a dressing material according to the invention. | 2010-01-21 |
20100015191 | DEVICE AND METHOD FOR CONTROLLING INSECTS - The present invention provides novel insecticidal devices, and methods for controlling insects in a homeothermic animal. | 2010-01-21 |
20100015192 | HYDROCOLLOID CARRIER BEADS WITH INERT FILLER MATERIAL - This invention discloses carrier beads comprising a hydrocolloid polymer comprising at least one inert filler material, wherein the at least one filler material provides improved properties including increased mechanical strength and/or reduced porosity relative to a bead without said at least one filler. The beads are useful per se or for delivery of active agents. Methods for preparation of the beads and the uses thereof are described particularly for controlling the rate of release an active agent from said bead. | 2010-01-21 |
20100015193 | Antibacterial Substrate and Method of Manufacturing the Same - An antibacterial substrate of the present invention includes a substrate and a plurality of antibacterial metal islands formed on the surface of the substrate. The antibacterial metal islands are exposed to an external atmosphere. The average value of contact angles between the substrate and the respective antibacterial metal islands is 90 degrees or less, as measured on the basis of results of surface observation with a scanning electron microscope. | 2010-01-21 |
20100015194 | PROCESS FOR THE PRODUCTION OF WOOD-BASED MATERIALS - Process for the production of wood-based materials containing wood parts, comprising the steps
| 2010-01-21 |
20100015195 | INJECTABLE DEPOT COMPOSITIONS AND IT'S PROCESS OF PREPARATION - Novel injectable depot compositions are provided comprising at least one active agent(s) optionally with one or more pharmaceutically acceptable excipient(s) in the form of a multi-component system preferably comprising at least two components which when administered to a subject in need thereof forms an in situ gel depot or implant at the site of injection upon contact with body fluids. Also described are process for preparation of such compositions and method of using such compositions. | 2010-01-21 |
20100015196 | Drug Depot Implantable Within a Joint - Methods and compositions for treating a tissue within a synovial joint in a patient in need of such treatment are provided. The methods and compositions involve inserting a drug depot through the synovial joint and attaching the drug depot to the inside of the synovial joint capsule so that the drug depot does not substantially interfere with movement of the joint, wherein said depot comprises a polymer and at least one pharmaceutical agent. | 2010-01-21 |
20100015197 | AMPHIPHILIC PEPTIDES AND HYDROGEL MATRICES THEREOF FOR BONE REPAIR - The present invention relates to the field of tissue engineering and more specifically to amphiphilic peptides and peptide matrices thereof useful in vitro and in situ biomineralization and inducing bone repair. The present invention provides peptides, which are useful in hydrogels and other pharmaceutical compositions, and methods and kits of use for bone repair and promotion of biomineralization. Certain hydrogels according to the invention comprise cells within or adhered to the peptide matrix. | 2010-01-21 |
20100015198 | TRANSPLANTS ENCAPSULATED WITH SELF-ELASTIC CARTILAGE AND METHOD OF PREPARING THE SAME - Disclosed is an implantable microparticle in which a transplant is encapsulated with elastic cartilage derived from the subject receiving the transplant. Also disclosed is a method of preparing an implantable microparticle, comprising (1) isolating elastic cartilage from a subject receiving a transplant; (2) multiplying the elastic cartilage through subculture; (3) mixing the elastic cartilage and the transplant, and subjecting a resultant mixture to shaking culture in order to allow the elastic cartilage to become attached around the transplant; and (4) isolating microparticles in which the transplant is encapsulated with the elastic cartilage. | 2010-01-21 |
20100015199 | METHOD FOR SUPPRESSING GENERATION OF A TERATOMA - The present invention provides a method for suppressing generation of a teratoma of an undifferentiated cell, preferably an ES cell. A biological material obtainable by the method and a therapeutic method for transplanting the biological material into a subject are also provided. | 2010-01-21 |
20100015200 | Drug Delivery Medical Device - Provided is a coated implantable medical device, comprising: a substrate; and a coating disposed on said substrate, wherein said coating comprises at least one polymer and at least one pharmaceutical agent in a therapeutically desirable morphology and/or at least one active biological agent and optionally, one or more pharmaceutical carrying agents; wherein substantially all of pharmaceutical agent and/or active biological agent remains within said coating and on said substrate until the implantable device is deployed at an intervention site inside the body of a subject and wherein upon deployment of said medical device in the body of said subject a portion of said pharmaceutical agent and/or active biological agent is delivered at said intervention site along with at least a portion of said polymer and/or a at least a portion of said pharmaceutical carrying agents. | 2010-01-21 |
20100015201 | IMPLANT WITH COATING - The present invention concerns an implant with a molecularly imprinted polymer coating, a process for its synthesis, a molecularly imprinted polymer, as well as a process for its synthesis and its use as well as a process for the treatment or prophylaxis of certain disease conditions by implantation of an implant in accordance with the invention according to the respective independent claims. | 2010-01-21 |
20100015202 | CANCELLOUS CONSTRUCT WITH SUPPORT RING FOR REPAIR OF OSTEOCHONDRAL DEFECTS - The invention is directed toward an osteochondral repair assembly comprising a shaped allograft construct comprising an unbalanced barbell-shaped cylindrical cancellous bone primary member formed with a mineralized cylindrical base section having a smaller diameter cylindrical stem leading to a second cylindrical section which is demineralized. A mineralized ring-shaped support member is forced over the compressed demineralized second demineralized the aperture of the ring-shaped member to fit around the stem with one ring surface being adjacent the bottom surface to the second cylindrical section and the opposite ring surface being adjacent the upper surface of the mineralized cylindrical base section. | 2010-01-21 |
20100015203 | BIOCOMPATIBLE FIBRINOGEN MATRIX ON A SOLID SUPPORT - The present invention provides a non-clottable matrix on a solid support comprising immobilized and crosslinked fibrinogen. The matrix may further comprise, in and/or on the matrix, one or several biologically active compound(s) and/or pharmacological substance(s). The matrix may be composed of one or several fibrinogen layer(s). The solid support according to the present invention may be selected from the group consisting of orthopaedic devices, implants, stitches, stents, pins, screws, plates, and sutures. | 2010-01-21 |
20100015204 | CELL CARRIER AND CELL CARRIER CONTAINMENT DEVICES CONTAINING REGENERATIVE CELLS - The present invention relates to a device comprising a cell carrier portion containing regenerative cells, e.g. stem and progenitor cells, and a cell carrier containment portion. The device is useful for the treatment of bone related disorders, including spinal fusion related disorders and long bone or flat bone related defects. The device may be used in conjunction with disclosed automated systems and methods for separating and concentrating regenerative cells. | 2010-01-21 |
20100015205 | BIOCOMPATIBLE AMINO ACID ANHYDRIDE POLYMERS - Biocompatible amino acid anhydride polymers for use in tissue engineering, and methods for their preparation and use. | 2010-01-21 |
20100015206 | MEDICAL DEVICES HAVING METAL COATINGS FOR CONTROLLED DRUG RELEASE - Medical devices having a plurality of nanoparticles disposed over a surface of the medical device. The nanoparticles have a core comprising a therapeutic agent and a shell surrounding the core, wherein the shell comprises a metal. A barrier layer is disposed over the nanoparticles. The barrier layer is water-permeable and comprises a metal that may be different from the metal used in the nanoparticle shells. In certain embodiments, the metal in the barrier layer undergoes galvanic corrosion. Also disclosed are medical device having a reservoir containing a therapeutic agent, with nanoparticles and a barrier layer being disposed over the reservoir; and medical devices having multiple barrier layers and multiple reservoirs containing therapeutic agents. | 2010-01-21 |
20100015207 | Methods for Treating Oral Cavity Infections with Chlorine Dioxide - Methods, devices, compositions, and systems for the alleviation of oral tissue infections by administration of chlorine dioxide are provided. | 2010-01-21 |
20100015208 | ANTIBACTERIAL WOUND DRESSING - The present invention relates to wound dressings, in particular to an antibacterial wound dressing based on silvered gel-forming fabric and to a process for the manufacture of such a wound dressing. | 2010-01-21 |
20100015209 | Patch and patch preparation - Provided is a patch having good adhesion property, which stably maintains the quality for a long time. | 2010-01-21 |
20100015210 | Patch and patch preparation - Provided is a patch having good adhesion property, which stably maintains the quality for a long time. | 2010-01-21 |
20100015211 | Combination Approaches For Generating Immune Responses - The present invention relates to methods, polypeptides, and polynucleotides encoding immunogenic identical or analogous HIV polypeptides derived from the same or different strains within an HIV subtype and/or different subtypes. Uses of the polynucleotides and polypeptides in combination approaches for generating immune responses are also described. The combination approaches described herein induce broad and potent immune responses against diverse HIV strains from multiple strains within a given subtype and against diverse subtypes. Formulations of compositions for generating immune responses and methods of use for such compositions are also disclosed. | 2010-01-21 |
20100015212 | IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS - Knockout of the meningococcal mltA homolog gives bacteria that spontaneously release vesicles that are rich in immunogenic outer membrane proteins and that can elicit cross-protective antibody responses with higher bactericidal titres than OMVs prepared by normal production processes. Thus the invention provides a bacterium having a knockout mutation of its mltA gene. The invention also provides a bacterium, wherein the bacterium: (i) has a cell wall that includes peptidoglycan; and (ii) does not express a protein having the lytic transglycosylase activity of MltA protein. The invention also provides compositions comprising vesicles that, during culture of bacteria of the invention, are released into the culture medium. | 2010-01-21 |
20100015213 | Compositions and Methods Using Same for Delivering Agents Into a Target Organ Protected by a Blood Barrier - A method of delivering a pharmaceutical agent into a target organ protected by a blood barrier is provided. The method comprising administering to a subject in need thereof an amount of liposomes which comprise the pharmaceutical agent, the amount and the liposomes are selected such that the liposomes accumulate in cells of an immune system of the subject to thereby generate liposome loaded immune cells, the liposome loaded immune cells become activated and cross the blood barrier, and an effective amount of the pharmaceutical agent is released from the liposomes in the target organ of the subject. | 2010-01-21 |
20100015214 | Novel Trans-Adjuvant System - The present invention relates to a novel adjuvant system that generates an efficient immune response against antigens of various origins while reducing the risk of toxic side effects attendant to the use of known adjuvants. The novel adjuvant of the present invention comprises virosomes and allows antigenic molecules to be bound to or encapsulated in a variety of delivery vehicles which are easier to prepare for virosomes. | 2010-01-21 |
20100015215 | Use of Glycolipids as Adjuvants - The present invention relates to adjuvants of the glycolipid type and their uses in pharmaceutical compositions, like in vaccines. In particular, the present invention provides new uses of compounds useful as adjuvants for prophylactic and/or therapeutic vaccination in the treatment of infectious diseases, inflammatory diseases, autoimmune diseases, tumours and allergies. The compounds are particularly useful not only as systemic, but preferably as mucosal adjuvants. | 2010-01-21 |
20100015216 | METHODS AND MATERIALS FOR TREATING ACNE - Compositions and methods for the treatment of acne are based upon a first therapeutic agent which is one or more members selected from the group consisting of: salicylic acid, azelaic acid, adapalene, benzoyl peroxide, and antibiotics; and a second therapeutic agent which comprises a taurine species. The two agents may be present in a single preparation and applied to the skin simultaneously, or they may be present in two separate preparations and applied to the skin sequentially. The taurine species may comprise free taurine, taurine salts, taurine esters, taurine complexes, taurine conjugates and taurine precursors either singly or in combination. The composition may include a liposomal carrier. Further disclosed are specific preparations and methods used for the treatment of acne. | 2010-01-21 |
20100015217 | Enhancing Pulmonary Host Defense via Administration of Granulocyte-Macrophage Colony Stimulating Factor - The present invention provides methods for enhancing pulmonary host defense in a subject by administering via inhalation an effective amount of granulocyte-macrophage colony stimulating factor or a functional homologue thereof. Methods of the present invention are useful in alleviating symptoms and/or treating pulmonary diseases or conditions including, but not limited to lung cancer, | 2010-01-21 |
20100015218 | COMPOSITIONS AND METHODS FOR POTENTIATED ACTIVITY OF BIOLOGICALLY ACTIVE MOLECULES - The present invention relates to novel compositions and methods for potentiating the activity of biologically active molecules in conjunction with one or more delivery vehicles and one or more carrier molecules. Specifically, the invention features the use of a carrier molecule in combination with a delivery vehicle and a biologically active molecule of interest to potentiate the activity of the biologically active molecule. The carrier molecule can be biologically inert, inactive, or attenuated; or can alternately be biologically active in the same or different manner than the biologically active molecule of interest. Specifically, the invention features novel particle forming delivery agents including cationic lipids, microparticles, and nanoparticles that are useful for delivering various biologically active molecules to cells in conjunction with a carrier molecule. The invention also features compositions, and methods of use for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of gene expression and/or activity in a subject or organism that are delivered intracellularly in conjunction with a carrier molecule. In various embodiments, the invention relates to novel cationic lipids, microparticles, nanoparticles and transfection agents that effectively transfect or deliver biologically active molecules, such as antibodies (e.g., monoclonal, chimeric, humanized etc.), cholesterol, hormones, antivirals, peptides, proteins, chemotherapeutics, small molecules, vitamins, co-factors, nucleosides, nucleotides, oligonucleotides, enzymatic nucleic acids, antisense nucleic acids, triplex forming oligonucleotides, 2,5-A chimeras, allozymes, aptamers, decoys and analogs thereof, and small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules, to relevant cells and/or tissues, such as in a subject or organism, in conjunction with one or more carrier molecules. Such novel cationic lipids, microparticles, nanoparticles and transfection agents that are used in conjunction with one or more carrier molecules are useful, for example, in providing compositions to prevent, inhibit, or treat diseases, conditions, or traits in a cell, subject or organism. | 2010-01-21 |
20100015219 | PHARMACEUTICAL COMPOSITIONS OF ACTIVE SUBSTANCES DIFFICULT TO IMPROPERLY DIVERT FROM THEIR INTENDED ROUTE OF ADMINISTRATION - A solid pharmaceutical composition in the form of a gel capsule containing at least one active ingredient and also at least one gelling agent chosen from cellulose derivatives such as hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, ethylmethylcellulose, sodium carboxymethylcellulose (CMC) and calcium carboxymethylcellulose, and at least one disintegrating agent, the gelling agent and the disintegrating agent being present in a ratio by weight of 0.3 to 0.7/1 and the content by weight of gelling agent(s) being from 10% to 20% of the composition, and method for preparing same. | 2010-01-21 |
20100015220 | NIACIN AND NSAID COMBINATION THERAPY - Provided are pharmaceutical compositions and methods for preventing or reducing niacin-induced flushing comprising an aspirin component and a niacin component having different release profiles. Also provided are methods and compositions for preventing or reducing niacin-induced flushing comprising niacin, aspirin and a lipid-lowering drug other than niacin. | 2010-01-21 |
20100015221 | ORALLY RAPID DISINTEGRATING TABLET PREPARATION COMPRISING FAT-SOLUBLE ACTIVE INGREDIENTS - The present invention provides an orally rapid disintegrating tablet preparation that contains a high dose of a fat-soluble active ingredient, that exhibits excellent disintegration characteristics in the oral cavity, and that can be produced by a dry tabletting method. The present invention also provides a method of producing an orally rapid disintegrating tablet preparation. The present invention discloses an orally rapid disintegrating tablet preparation that is obtained by tabletting a uniform mixture prepared by mixing saccharide alcohol, crystalline cellulose, and a lubricant with a granule that has been produced by the adsorption of a fat-soluble active ingredient on a porous material. | 2010-01-21 |
20100015223 | Crush-Resistant Tablets Intended to Prevent Accidental Misuse and Unlawful Diversion - Water-insoluble matrix tablets which are capable of prolonged release of active principles liable to be diverted for drug addiction purposes, the said active principles being dispersed within a tabletting matrix composed of at least one excipient selected from the group consisting of pH-independent, water-insoluble delay polymers, inorganic excipients and mixtures thereof, and exhibiting a crush resistance of at least 4 MPa. | 2010-01-21 |
20100015224 | PROGRAMMABLE BUOYANT DELIVERY TECHNOLOGY - The present invention is concerned with a system for spatially and temporally programmable delivery of an active agent. When administered orally, the System can be retained in the gastric region for a prolonged period of time. It comprises of a core (I), one or more layers (II, IV, V) coated over the core and a preformed hollow space (III). The invention also concerns with a process for preparation of the System and a method for treating/preventing diseases, by administering to a subject in need thereof, the System of the invention. | 2010-01-21 |
20100015225 | SOLID DISPERSION OF A NEUROKININ ANTAGONIST - Solid dispersion comprising (4R)-4-[N′-methyl-N′-(3,5-bistrifluoromethyl-benzoyl)-amino]-4-(3,4-dichlorobenzyl)-but-2-enoic acid N—[(R)-epsilon-caprolactam-3-yl]-amide or a pharmaceutically acceptable salt or solvate thereof and a carrier. Pharmaceutical compositions comprising such solid dispersion are useful to treat patients who have functional motility disorders of the viscera, especially irritable bowel syndrome or functional dyspepsia, or urinary bladder disorders, especially urinary incontinence. | 2010-01-21 |
20100015226 | BIORESORBABLE HYDROGEL - The invention relates to a water-swellable, hydrophilic, physically-crosslinked hydrogel which can slowly disintegrate in an aqueous medium. The inventive hydrogel essentially consists of albumin blood proteins which are bound in the form of a gel in a basic medium. The invention also relates to the use of said hydrogel as a bioresorbable separation membrane and to a method of preparing same. | 2010-01-21 |
20100015227 | DRIED ELECTRIFIED HYDROCOLLOID GELS HAVING UNIQUE STRUCTURE AND POROSITY - This invention discloses electrified freeze-dried hydrocolloid gels, having modified structures with improved properties, as well as methods for the preparation of these modified gels and their uses. Specifically gels modified by electrification and freeze-drying undergo changes including creation of concentric layers of gel and intervening spaces. | 2010-01-21 |
20100015228 | CONTROLLED RELEASE ION CHANNEL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS - Disclosed herein are compositions and methods for the treatment of otic disorders with ion channel modulators. In these methods, the ion channel modulator compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the ion channel modulator compositions and formulations onto the auris interna target areas, or via perfusion into the auris interna structures. | 2010-01-21 |
20100015229 | Pharmaceutical compositions - A process for the production of a composition comprising a water-insoluble statin which comprises the steps of: a) providing a mixture comprising: i) a water-insoluble statin ii) a water soluble carrier, iii) a solvent for each of the statin and the carrier, and b) spray-drying the mixture to remove the or each solvent and obtain a substantially solvent-free nano-dispersion of the statin in the carrier. | 2010-01-21 |
20100015230 | Bone Morphogenetic Protein Compositions - The present invention relates to compositions of bone morphogenetic proteins, particularly solid and liquid formulations of such proteins comprising one or more stabilizing excipients. The invention further provides methods of producing the compositions, kits comprising the compositions and methods of using the compositions in the treatment of diseases of skeletal and non-skeletal tissues. | 2010-01-21 |
20100015231 | LOW SWELL, LONG-LIVED HYDROGEL SEALANT - A low swell, long-lived hydrogel sealant formed by reacting a highly oxidized polysaccharide containing aldehyde groups with a multi-arm amine is described. The hydrogel sealant may be particularly suitable for applications requiring low swell and slow degradation, for example, ophthalmic applications such as sealing wounds resulting from trauma such as corneal lacerations, or from surgical procedures such as vitrectomy procedures, cataract surgery, LASIK surgery, glaucoma surgery, and corneal transplants; neurosurgery applications, such as sealing the dura; and as a plug to seal a fistula or the punctum. The low swell, long-lived hydrogel sealant may also be useful as a tissue sealant and adhesive, and as an anti-adhesion barrier. | 2010-01-21 |
20100015232 | NANOPARTICLES FOR NUCLEIC ACID DELIVERY - The present invention provides chitosan/RNA nanoparticles that are useful as research tools or medicaments. Preferably, the RNA part of the nanoparticle is a siRNA capable of modulating the expression of a target mRNA. The invention also provides methods for the preparation of chitosan/RNA nanoparticles. | 2010-01-21 |
20100015233 | anti-parasitic compositions - The present invention relates to nanodisperse antiparasitics and provides a composition comprising at least one water insoluble anti-parasitic drug and a water-soluble carrier material, wherein the water-insoluble anti-parasitic drug (preferably an Artemisinin-type drug or a quinine type drug) is dispersed through the carrier material in nano-disperse form having a peak diameter of the nano-disperse form below 1000 nm. The invention further provides an aqueous dispersion of a water insoluble anti-parasitic drug and a water-soluble carrier material, wherein the anti-parasitic drug is in nano-disperse form having a peak diameter of the nano-disperse form below 1000 nm, the invention further subsists in a process for preparing an anti-parasitic composition comprising a water insoluble anti-parasitic agent and a water-soluble carrier, which comprises the steps of either: a) providing an emulsion comprising a solution of the anti-parasitic agent in a water-immiscible solvent for the same, and an aqueous solution of the carrier, or providing a mixture comprising at least one non-aqueous solvent optional water a water-soluble carrier material soluble in the mixture and a water-insoluble anti-parasitic agent soluble in the mixture, and, b) drying the emulsion (preferably by spray drying) to remove water and the water-immiscible solvent to obtain a substantially solvent-free nano-dispersion of the anti-parasitic agent in the carrier. | 2010-01-21 |
20100015234 | Pharmaceutical preparations and their manufacture - A method for making a composition comprising active particles comprising an active substance comprises the steps of a) providing an emulsion having a dispersed phase comprising a solution of the active substance in a solvent and b) inducing the formation, in the emulsion, of solid particles comprising the active substance. The particles may be isolated from the emulsion. Active particles having a normalized kurtosis of at least 5 and a mean diameter of less than 100 μm are provided. | 2010-01-21 |
20100015235 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS - Provided are electrokinetically-altered fluids (gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for use in treating inflammatory neurodegenerative condition or disease or at least one symptom thereof. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ionic aqueous fluids optionally in combination with other therapeutic agents. Particular aspects provide for regulating or modulating intracellular signal transduction associated with said inflammatory responses by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g., tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular routes of administration or formulations for the electrokinetically-altered fluids (e.g., electrokinetically-altered gas-enriched fluids and solutions) and therapeutic compositions. | 2010-01-21 |
20100015236 | PESTICIDE NANOPARTICLES OBTAINED FROM MICROEMULSIONS AND NANOEMULSIONS - The present invention provides a redispersible powder and aqueous dispersions of nanoparticles of water insoluble organic pesticides. The invention further provides methods for preparing the redispersible powder and the aqueous dispersion, wherein the methods include preparation of an oil-in-water nanoemulsion or microemulsion and solvent removal. The present invention also provides pesticidal compositions of the redispersible powder or aqueous dispersions, and their agricultural use in combating pests. | 2010-01-21 |
20100015237 | NSAID Delivery from Polyarylates - This invention provides biodegradable, sustained-release pharmaceutical compositions of non-steroidal, anti-inflammatory drugs (NSAIDs) formulated with biocompatible, biodegradable tyrosine-derived polyarylates. The compositionsare particularly suitable for localized delivery of NSAIDs for various disease states. For example, implantation of the compositions at the site of surgery leads to relatively high local concentrations of the NSAID to reduce or alleviate post-surgical pain. Long term zero order release of certain NSAIDs can also be provided by with certain polymer formulations. | 2010-01-21 |
20100015238 | Powder Compositions for Inhalation - A pharmacological powder for inhalation comprising fine particles of a drug and particles of a force-controlling agent, wherein the particles of said force-controlling agent are disposed on the surface of the active particles as either a particulate coating, or as a continuous or discontinuous film. The powder may further comprise particles of a carrier material for supporting the drug particles. The force-controlling agent may be selected from: amino acids, peptides and polypeptides having a molecular weight of from 0.25 to 1000 KDa; phospholipids; titanium dioxide; aluminium dioxide; silicon dioxide; starch; and salts of fatty acids. Also disclosed is a method of making such a powder for inhalation comprising mixing a force-controlling agent with particles of one or more pharmacologically active materials to obtain a mixture in which the particles of said force-controlling agent are disposed on the surface of the active particles as either a particulate coating, or as a continuous or discontinuous film. The mixing step may be achieved by sieving, mixing or blending, micronising and/or co-micronising the particles of one or more pharmacologically active material and particles of force-controlling agents. | 2010-01-21 |
20100015239 | Orally Disintegrating Solid Pharmaceutical Dosage Forms Comprising Delayed-Release Lansoprazole and Methods of Making and Using the Same - The present invention relates to non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising delayed-release lansoprazole, processes for preparing the dosage forms, and methods for treating one or more conditions with the dosage forms. | 2010-01-21 |
20100015240 | PROCESS FOR PREPARING MICROPARTICLES CONTAINING BIOACTIVE PEPTIDES - The present disclosure relates to processes for preparing microparticles comprising peptides and to microparticles prepared by such processes. Also disclosed are methods for delivering a bioactive peptide to a subject in need of treatment by the bioactive peptide. | 2010-01-21 |
20100015241 | AVIAN-BASED INSECT REPELLENT - The invention provides an insect repellent that repels flies, gnats, mosquitoes, lice, ticks, and fleas. The insect repellent comprises an avian-based extract, in particular an extract isolated from birds of the order Psittaciformes (parrots). The invention also provides an insect repellent composition about 5 volume% to about 75 volume % of the avian-based extract and about 95 volume % to about 25 volume % of a carrier vehicle. | 2010-01-21 |
20100015242 | USE OF A COMPOSITION FOR SKIN TREATMENT UNDER X-IRRADIATION - The invention relates to the use of a composition in the production of a dermatological agent for skin treatment under repeated X-irradiation. The composition includes oxygen-bearing asymmetrical lamellar aggregates of phospholipids and fluorocarbons as well as specific water-soluble antioxidants, said composition having a radical protection factor of at least 4000×10 | 2010-01-21 |
20100015243 | METHOD FOR PREPARING MATERIALS HAVING ANTITHROMBOTIC ACTIVITY FROM MUSKRAT MUSK AND MATERIALS OBTAINED FROM THE METHOD - Disclosed herein is a method of preparing an antithrombotic agent from muskrat musk and an antithrombotic agent having a high potency obtained therefrom, wherein the antithrombotic agent is prepared by treating muskrat musk with ethanol to obtain an ethanol extract; carrying out two normal phase column chromatographies while raising the combination ratio of hexane and ethyl acetate to obtain numerous fractions; carrying out thin layer chromatographies and identifying the material patterns of the fractions with UV lamps and 10% sulfuric acid to divide the materials which have a similar moving distance into groups; measuring a thrombin time of each group to isolate a group having a potent antithrombotic activity; carrying out a reverse phase column chromatography while raising the combination ratio of acetonitrile and water to obtain numerous fractions; and isolating an antithrombotic agent material having a high potency therefrom. According to the present invention which provides an antithrombotic agent having a high potency from muskrat musk, the value added of muskrat musk is raised. | 2010-01-21 |
20100015244 | Nano/Macroporous Bioactive Glasses Made by Melt-Quench Methods - The methods and materials described herein provide novel and simple procedures for the preparation of nano/macroporous glasses, in which the pore structure is characterized by interconnected pores of, e.g. both hundreds of micrometers and several to tens of nanometers in size. Such materials may be used for enhanced bone regeneration, bioscaffolds, drug delivery devices, and filtration media, among other uses. For example, silica-based bone tissue scaffolds are made with a controlled nano/macroporosity, which enhances bone regeneration performance. Also provided herein are new biocompatible CaO—Na | 2010-01-21 |
20100015245 | Combination of Copper Cations with Peroxides or Quaternary Ammonium Compounds for the Treatment of Biofilms - The present invention relates to a method of inhibiting biofilms by combinations of antimicrobials, particularly with their synergistic activity against bioFilms. The antimicrobials include combination of copper ion and quaternary ammonium compound or combination of copper ion and peroxide. The invention also include methods for inhibiting biofilm-induced microbial corrosion or fouling. | 2010-01-21 |
20100015246 | COMBINATION OF A LANTHANUM COMPOUND AND BONE ENHANCING AGENT FOR THE TREATMENT OF BONE DISEASES - The invention provides a method for enhancing bone formation, inhibiting osteoclastic differentiation and/or activating osteoblastic differentiation whereby to manage, treat or achieve prophylaxis of bone disease which comprises administering to a human or animal subject suffering from, or susceptible to bone disease a therapeutically or prophylactically effective amount of a lanthanum compound and a bone enhancing agent, such as vitamin D. | 2010-01-21 |
20100015247 | Carrageenan based antimicrobial compositions - Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more carrageenans, including lambda carrageenan. Also disclosed are methods for making and using the compositions. | 2010-01-21 |
20100015248 | Pharmaceutical composition - A pharmaceutical composition for the treatment of colds and influenza. The pharmaceutical composition is a mixture of: acetaminophen, diphenhydramine, dextromethorphan, arabinogalactan, vitamin C, zinc, olive leaf extract, resveratrol and elderberry extract. | 2010-01-21 |
20100015249 | Antitumor agent containing 6'-amidino-2'-naphthyl 4-guanidinobenzoate or salt thereof - It is an object of the present invention to provide novel antitumor agents which have a high therapeutic index while causing neither serious adverse effects nor drug resistance, both of which are the problems associated with existing antitumor agents. In particular, it is an object of the present invention to provide novel agents and therapies which are effective for pancreas cancer, for which no effective therapies and chemotherapeutic agents exist at this stage, and are also capable of inhibiting cancer metastasis and cancer filtration. The antitumor agents, more specifically the therapeutic agents for pancreas cancer and the cancer metastasis inhibitors, of the present invention contain as an active ingredient 6′-amidino-2′-naphthyl 4-guanidinobenzoate or a salt thereof or more specifically the mesylate thereof known as nafamostat mesilate (generic name; also referred to as “Futhan,” “FUT,” and “FUT175.”). Moreover, in another mode of the present invention, the above mentioned FUT is administered in combination with existing anticancer/antitumor agents, particularly preferably in combination with gemcitabine hydrochloride. | 2010-01-21 |
20100015250 | Thermally Stable Subsea Control Hydraulic Fluid Compositions - An aqueous hydraulic fluid composition comprising of one or more lubricants such as a monovalent metal salt, ammonium, or alkanolamine salt of a dicarboxylic acid, such as a C21 dicarboxylic acid is described in which the aqueous hydraulic fluid composition demonstrates increased thermal stability when exposed to elevated temperatures for a prolonged period of time while being able to tolerate the presence of 10% v/v synthetic seawater. The aqueous hydraulic fluid composition contains less than about 20% by weight (preferably none or substantially none) of an oil selected from the group consisting of mineral oils, synthetic hydrocarbon oils, and mixtures thereof. | 2010-01-21 |
20100015251 | Tooth Polishing Compositions and Methods of Tooth Polishing Without Mechanical Abrasion - A method of polishing a tooth surface without mechanical abrasion is provided. Kits and compositions are also provided. | 2010-01-21 |
20100015252 | Tooth Polishing Compositions and Methods of Tooth Polishing Without Mechanical Abrasion - A method of polishing a tooth surface without mechanical abrasion is provided. | 2010-01-21 |
20100015253 | Treatment of nail infections with no - Nitrogen oxide generating compositions are useful in the treatment of subungual infections, as NO has surprisingly been found to be able to penetrate the nail to exert an anti-fungal effect. | 2010-01-21 |
20100015254 | Use of tea-derived, theaflavin enriched extract to increase exercise performance and reduce exercise recovery time - This invention provides various methods such as a method for enhancing athletic exercise performance of a subject by administering to the subject a composition comprising a physiologically acceptable carrier and an extract of tea, wherein the extract comprises at least 20% by weight of theaflavins and wherein the composition is administered in an amount effective to enhance the subject's athletic performance. | 2010-01-21 |
20100015255 | COMPOSITIONS AND METHODS FOR TREATING HYPERCHOLESTEROLEMIA USING ORTANIQUE PEEL EXTRACT - The invention relates to compositions and methods for treating hypercholesterolemia, including methods for increasing HDL cholesterol levels, using a composition comprising an extract from the Ortanique peel. The invention also relates to compositions and methods for treating hypercholesterolemia, including methods for increasing HDL cholesterol levels, using a composition comprising substantially similar amounts of tetramethylscutellarein and nobiletin by weight and/or a composition comprising substantially similar amounts of tetramethylscutellarein, nobiletin, and tangeretin by weight. | 2010-01-21 |
20100015256 | HAIR GROWTH STIMULANT AND PREPARATION METHOD THEREOF - A hair growth stimulant is provided. The hair growth stimulant uses carbonized chestnut burrs that exhibit excellent stimulatory effects on hair restoration and hair growth effects without causing side effect and toxicity. The hair growth stimulant exhibits excellent stimulatory effects on hair restoration without causing any side effect and toxicity in humans and stimulates hair roots to greatly contribute to hair growth. Therefore, the hair growth stimulant is effective in preventing hair loss and grayness. In addition, the hair growth stimulant is formulated into a cream or ointment preparation, which is highly effective in promoting the restoration of hair, to considerably shorten the time required for the treatment of hair loss. Furthermore, the hair growth stimulant uses vegetable ingredients only, thus causing no side effect in humans. Moreover, the hair growth stimulant is softly applicable to the scalp, thus offering convenience in use. | 2010-01-21 |
20100015257 | Composition For Treating Atopic Dermatitis Comprising Extracts Of Bamboo And Scutellaria - The present invention relates to a composition comprising of plant extract as an active component, specifically, Bamboo extract and | 2010-01-21 |
20100015258 | Rice Bran Extracts and Methods of Use Thereof - The present invention relates to stabilized rice bran extracts that modulating glucose uptake and FABP4 activities that control glucose uptake in to cells and carbohydrate and fat metabolism. These stabilized rice bran extracts are useful for treating hypoglycemia, diabetes, and obesity. | 2010-01-21 |
20100015259 | Composition and method for improving human concentration, memory and other cognitive brain - This formulaic composition has synergistic effects on the mental function of humans including reduction of mental fatigue, maintenance and enhancement of concentration and mental vigor. The main components are theanine, at levels in excess of 200 mg/dose, and Gingko Biloba extract. Further additions include small amounts of Vitamins B | 2010-01-21 |
20100015260 | Development of biochemically standardized extracts from fresh rhizomes of turmeric (curcuma longa) for treatment of diseases caused by hyperuricemia - The present invention pertains to methods for extraction of turmeric ( | 2010-01-21 |
20100015261 | HERBAL PREPARATION FOR SLEEP APNEA RELIEF - An herbal preparation for relief of sleep apnea contains lobelia and/or lobelia extract material acting as a respiratory stimulant in combination with meadowsweet to reduce nausea. Optional but preferred materials also include thyme to increase pleural activity, together with chamomile and cramp bark to facilitate relaxation. | 2010-01-21 |
20100015262 | NOVEL USE OF COMPOUNDS AND COMBINATIONS OF COMPOUNDS FOR IMPROVING THE PHYSICAL APPEARANCE - The present invention is directed inter alia to the use of at least one compound selected from the group consisting of (−)-epigallocatechin gallate, resveratrol, eicosapentaenoic acid, docosahexaenioic acid, rose hip extract/concentrate, hydroxytyrosol, lycopene, lutein, β-cryptoxanthin, zeaxanithin and derivatives thereof, for the treatment of cellulite, for the prevention of the development of mild cellulite, for the prevention of the progression of mild cellulite to severe cellulite, for smoothening the micro relief of the skin, for maintaining or increasing the tensile properties of the skin, and/or for reducing the fat mass and the circumference at the hips and thighs, as well as to the corresponding cosmetic and medical methods. | 2010-01-21 |
20100015263 | CONTROLLED RELEASE AURIS SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS - Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with auris sensory cell modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s). | 2010-01-21 |
20100015264 | FILLING SHOE FOR ROTARY TABLET PRESSES - A filling shoe for rotary tablet presses, comprising a filling shoe housing with at least one discharge opening for a starting product which is to be compressed and with a seal for sealing the gap between the die plate and filling shoe housing, which seal can be fastened exchangeably to a bottom wall of the filling shoe housing. In order to make it possible to achieve shorter downtimes when changing the seals, the seal in the mounted state is fastened to the bottom wall by means of magnetic force. Changing the seal can then take place, if appropriate even without any further aids, by overcoming the magnetic holding force and replacing the seal with a new seal. The invention also relates to the seal for sealing the gap, which seal can be fastened according to the invention by means of magnetic elements. | 2010-01-21 |
20100015265 | PRESSURE BLADDER AND METHOD FOR FABRICATION - A pressure bladder has a seamless shell made from an elastomeric material, an inner cavity, and a pressure port. The bladder can also have a reinforcement layer and an outer layer to reinforce the bladder and define the bladder's outer dimensions and pressure profile. In order to fabricate the bladder, a mandrel is formed, and the pressure port is positioned on the surface of the mandrel. The mandrel is then coated with the elastomeric material and placed in a mold. A reinforcement layer is added and an elastomeric material is injected into the mold to form the outer layer. The mandrel is then removed from the mandrel assembly by applying heat and pressure to the bladder such that the mandrel can be extracted through the pressure port. | 2010-01-21 |
20100015266 | DEVICE FOR MELT-SPINNING SYNTHETIC FILAMENTS - A device for melt-spinning synthetic filaments includes a spin-die manifold for holding at least one bank of spinnerets and heating device for heating the bank of spinnerets. At least one spinneret with second heating device for heating the spinning pump is allocated to the bank of spinnerets and the spinning pump and bank of spinnerets are interconnected by a melt line. To achieve a user-friendly arrangement for the bank of spinnerets and the spinning pump, the pump and the second heating device are held by a separate pump support which is placed at a distance from the spin-die manifold. This allows the spinning pump to be heated independently of the spin-die manifold. | 2010-01-21 |
20100015267 | Dies for Making Extruded Synthetic Wood and Methods Relating Thereto - The present invention is directed to extrusion dies for making extruded synthetic wood and methods relating thereto. The dies include adapter dies, transition dies, stranding dies, and molding dies. The adapter dies include a channel with a restricted cross-sectional area. The stranding dies include a plurality of non-uniform channels that differ in length, cross-sectional area, cross-sectional shape, or combinations thereof. The transition dies are coordinately configured with the stranding die to adjust the flow rate of the extrudate. Particular configurations of dies upstream of the molding die allow for higher compression ratios in the molding die than previously feasible. Each of the dies described herein may be used individually with standard dies known in the alt. Alternatively, the dies may be used in combination to form integrated units. The dies described herein allow for making stronger, more consistent synthetic wood at greater output rates than previously possible. | 2010-01-21 |
20100015268 | Method for multilayer molding of thermoplastic resins and multilayer molding apparatus - A multilayer-molding method includes the steps of mixing at least one thermoplastic resin selected from a plurality of types of thermoplastic resins with a bubble-nucleating agent and a foaming gas, injecting the plurality of types of thermoplastic resins into a mold cavity such that the thermoplastic resins are layered in the mold cavity, and then, after increasing the volume of the mold cavity, foaming the at least one thermoplastic resin mixed with the bubble-nucleating agent and the foaming gas. The multilayer-molding method is characterized in that the foaming gas is supplied at a pressure of 0.1 MPa or more but less than 1.0 MPa to at least one injection-molding machine selected from a plurality of injection-molding machines, and that the thermoplastic resin plasticized in the injection-molding machine is mixed with the foaming gas. | 2010-01-21 |
20100015269 | BLOW MOLDING MACHINE WITH AIR CONDITIONING - A blow molding machine with air conditioning that while minimizing the introduction rate of outside air, realizes maintaining of constant temperature in not only a plant building but also the interior of a blow molding machine and production of a bottle as a final configuration with stability in its measurement value. The blow molding machine with air conditioning is constructed so that air for use in biaxially stretching blow molding together with hot air of heating zone ( | 2010-01-21 |
20100015270 | INNER CAVITY SYSTEM FOR NANO-IMPRINT LITHOGRAPHY - A nano-imprint lithography template system having a support layer with at least one port, and a patterned surface layer coupled to the support layer. Coupling of the patterned surface layer to the support layer forms a cavity. Pressure within the cavity is controlled through the port of the support layer. | 2010-01-21 |
20100015271 | SPECIFIC-LIGHT-CURED AND PRESSURE-DIFFERENTIAL EMBOSSING APPARATUS - A specific-light-cured and pressure-differential embossing apparatus for embossing a specific-light-cured layer on a substrate includes a housing assembly, a mold, an elastic driving module, a pressure-difference generating module, and a specific light providing module. The substrate and the mold are disposed in a chamber of the housing assembly. The mold faces the specific-light-cured layer on the substrate. The elastic driving module is disposed in the chamber to divide the chamber into a first sub-chamber and a second sub-chamber. The pressure-difference generating module, connected to the first sub-chamber and the second sub-chamber, generates a pressure difference between the first sub-chamber and the second sub-chamber, and drives the elastic driving module to move and thus to drive the mold to move and press the specific-light-cured layer. The specific light providing module provides specific light to the specific-light-cured layer to cure the specific-light-cured layer. | 2010-01-21 |
20100015272 | PELLETING MACHINE - The invention relates to a pelleting machine with a die table having at least one die plate, dies associated with the die plate and a feed device for feeding a material to be pressed into the die plates. The feed device includes a feed shoe which is arranged substantially parallel to a surface of the die table and has at least one feed opening which is arranged or can be arranged in the region of the die plates. The pelleting machine further includes a sealing device disposed between the feed shoe and the die table. | 2010-01-21 |
20100015273 | STRETCHING APPARATUS FOR WEB OF THERMOPLASTIC SYNTHETIC RESIN - A stretching apparatus for thermoplastic synthetic resin improved so as to ensure that a web can be easily stretched over its entire width. The stretching apparatus | 2010-01-21 |
20100015274 | INJECTION MOULDING NOZZLE AND TIP THEREFOR - An injection moulding tip ( | 2010-01-21 |
20100015275 | INJECTION-MOLDING NOZZLE - The invention relates to an injection-molding equipment nozzle ( | 2010-01-21 |
20100015276 | Increased Stability Of Flavor Compounds - The present invention is directed to the treatment of reactive thiol groups (—SH) found in thiol-containing flavor compounds by a highly selective enzymatic conversion into aroma-active disulides compounds using sulfhydryl oxidase. | 2010-01-21 |
20100015277 | Malolactic fermentation of wine - A method for improving the malolactic fermentation in wines comprising conducting the malolactic fermentation using lactic acid bacteria with organic alkaline or neutral dispersing agent. | 2010-01-21 |
20100015278 | ACIDULATE COMPOSITION AND METHODS FOR MAKING AND UTILIZING THE SAME - A baking additive for enhancing the shelf-life and maintaining the volume of a baked product, and methods for producing and using the same. The baking additive comprises a blend of an non-encapsulated acidulate and an acidulate having a fat-based encapsulating coating that is degradable by heat. The combination of the encapsulated and non-encapsulated provides strategic release of the acidulates throughout the baking process such when the baking additive is added to a dry dough mix, the acidulates can sufficiently decrease the pH of the dry dough mix to prevent microbial contamination without interfering with glutton elasticity or the chemical leavening system. | 2010-01-21 |
20100015279 | Method and Formulations For Gluten-Free Bakery Products - Provided herein are gluten-free compositions which can be made into a dough. The gluten-free dough can be subjected to a sheeting or pressing process and therefore can be prepared easily in commercial settings. The dough comprises gluten-free flour, modified starch, protein, leavening agents; oil and water. | 2010-01-21 |
20100015280 | Functional No-Trans Oils With Modulated Omega-6 To Omega-3 Ratio - The functional oils provided herein are formulated for low saturated fat content, rapid crystallization, no trans content, high alpha-linolenic acid (ALA), and a specific ratio of omega-6 (linoleic; C18:2) to omega-3 (alpha-linolenic; C18:3) acids. The functional oils provided herein are formulated with liquid vegetable oil and concentrated saturated fatty acid fraction, where the concentrated saturated fatty acid fraction is derived principally from interesterified blends of liquid oil and fully hydrogenated vegetable oil. The unique ensemble of desirable functional and nutritional properties has not previously been simultaneously formulated into lipid compositions suitable for shortening and spray oil applications. | 2010-01-21 |
20100015281 | FERMENTED FOOD CONTAINING BIFIDOBACTERIUM BACTERIA AND METHOD FOR PRODUCING THE SAME - Provided is a fermented food containing an extract of at least one plant material selected from the group consisting of turmeric, | 2010-01-21 |
20100015282 | Conversion Of Soybean Hulls To Ethanol And High-Protein Food Additives - Soybean hull fermentation methods that produce food additives having a high protein content are disclosed. The protein is generally present as unhydrolyzed and non-racemized protein that possesses a complete amino acid profile. The food additive is suitable for consumption by a wide variety of animals, including humans. | 2010-01-21 |
20100015283 | Method of Preparing Powder Kimchi and Kimchi Composition Using the Same - Disclosed herein are a method for preparing kimchi powder and a kimchi composition containing said kimchi powder. The preparation method comprises the steps of: adding one or more selected from the group consisting of skimmed milk powder, skimmed milk, starch, dextrin, soybean milk, cheese and glycerol, to crushed or chopped kimchi produced by grinding or crushing kimchi, before or after a fermentation process; and freeze-drying the mixture so as to powder it. | 2010-01-21 |